Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose aspirin vs placebo in twin pregnancies for prevention of pre-eclampsia
2019-003341-15Phase 3Active
- Sponsor
- Fundación para la Formación e Investigación Sanitaria
- Start
- Jun 2022
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in preeclampsia comparing Low-dose aspirin with Placebo (2 arms). Primary endpoint: Incidence of preterm pre-eclampsia with delivery <37 weeks. Started Jun 2022; status: active.
02
Drugs
aspirin
03
Conditions
preeclampsia
Beyond the preview
Go deeper on 2019-003341-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-003341-15.